1. Introduction {#s0005}
===============

Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder (FGID) characterized by abdominal pain or discomfort with defecation disorders ([@bb0060]). It is commonly present in children and adolescences without abnormality on physical examination. Prevalence of IBS is higher than other gastrointestinal disorders, in developing and developed countries which is about 10--15% and 21% in school children and adolescences respectively in the UK. In Asia, the IBS prevalence were 2.9--15.6% in school children and 5.8--25.7% among adolescences ([@bb0080]; [@bb0035]; [@bb0030]). A lower prevalence was observed among adolescences in Jakarta ([@bb0040]). IBS can be categorized into four subtypes according to Rome III criteria, Bristol scale: Diarrhoea type, Constipation type, Mixed type and Unclassified ([@bb0110]).

The exact aetiology of IBS remains to be determined, whether it is caused by hereditary or environmental factors such as *Blastocystis* infection, as was reported in Pakistan ([@bb0110]). It is possibly due to complex interaction between infection, inflammation, visceral hypersensitivity, allergy and gut motility disorders ([@bb0035]; [@bb0010]). *Blastocystis* is a common intestinal parasite with extensive genetic variability; its pathogenic potential in human intestine is still controversial because it is found in symptomatic and asymptomatic individuals ([@bb0145]; [@bb0175]; [@bb0170]; [@bb0115]). There has been quite a few studies looking for the association between IBS and *Blastocystis* but has not come into one consensus on the pathogenicity of *Blastocystis* in IBS. Recent surveys on parasites infection among children and adolescence in Indonesia showed 30% and 40% *Blastocystis* spp. prevalence respectively ([@bb0135]; [@bb0155]). The clinical consequences of *Blastocystis* infection are mainly diarrhoea or abdominal pain with nonspecific gastrointestinal symptoms ([@bb0145]; [@bb0175], [@bb0170]; [@bb0115]).

This study aimed to conduct extensive analysis on IBS in the community to find the risk factors of IBS in adolescence and IBS relation to *Blastocystis* infection.

2. Methods {#s0010}
==========

A prospective cross-sectional study was carried out in two stages. The first stage aimed to identify the risk factors of IBS among adolescences. The second stage was to analyse the role of *Blastocystis* and its subtypes in IBS and non-IBS groups. According to sample size formula calculation, a minimum number of 70 subjects in each group were required for statistical analyses.

2.1. Study population {#s0015}
---------------------

To identify the risk factors associated to IBS among adolescences, a community-based survey was conducted with comparative cross sectional two groups among six senior high school students in Palembang-South Sumatra which is one-hour flight from Jakarta, followed by a minimum 2 h local transport. Student\'s general characteristics and physical examination were recorded. Nutritional status was determined based on anthropometric examination and plotted onto the CDC growth chart. The Rome III criteria for IBS diagnosis was applied i.e. abdominal discomfort or pain at least once per week for \>2 months and it was associated with at least two of the three following features for at least 25% of the time: (1) Abdominal pain improved with defecation, (2) Onset associated with change in defecation frequency, (3) Onset associated with change in stools consistency.

The inclusion criteria were good health; those with chronic diseases such as asthma, diabetes mellitus, all variant of heart, renal and blood diseases, congenital anomaly were excluded. Those who had received antibiotics and antiparasitic treatment (metronidazole, tinidazole, albendazole) in the last two weeks were also excluded. A team was formed consisting of five physicians, trained in detail for IBS identification and understanding the questionnaire. Questionnaire was developed, based on the recommendation of the Rome III Criteria and distributed among the students on school visits; understanding of the questions was assisted by the investigators ([@bb0065]). Inform consent was obtained from school administrators and parents before commencing the study. There were 454 adolescences eligible to participate in the first stage of this study. They were interviewed and underwent physical examination to identify the presence of IBS, and then were classified into IBS and non-IBS groups.

To identify the association between IBS and *Blastocystis* infection; subjects from each group were further selected by simple random sampling, with minimum 70 subjects for each group according to the sample size formula calculation ([Fig. 1](#f0005){ref-type="fig"}).Fig. 1Study workflow diagram.\^minimum sample requirement based on the sample size calculation formula.Fig. 1

2.2. Diagnostic criteria for IBS and IBS subtypes ([@bb0110]) {#s0020}
-------------------------------------------------------------

Subjects with IBS were classified into four subtypes according to Rome III-Bristol scale: IBS with constipation (IBS-C) when hard or lumpy stools for at least ≥25% of the time; IBS with diarrhoea (IBS-D) when loose, mushy or watery stools for at least ≥25% of defecations; IBS with either hard or lumpy stools and loose, mushy or watery stools for ≥25% of defecations were identified as mixed IBS (IBS-M). Those fulfilled the criteria without diarrhoea and constipation were grouped as unclassified IBS (IBS-U).

2.3. Identification of *Blastocystis* spp. {#s0025}
------------------------------------------

Microscopic examination with 1% lugol solution was carried out on sub-sample 207 stools, originated from all IBS individuals (n = 137) and 70 non-IBS ([Fig. 1](#f0005){ref-type="fig"}). Approximately 2 mg of feces was smeared on a glass slide with one drop lugol solution and covered with a cover slip, examined under medium power (40×) objective lens. Stools positive for *Blastocystis* spp. were cultured in Jones\' medium supplemented with 10% horse serum ([@bb0085]) to amplify the number of *Blastocystis*. Cultures were incubated at room temperature then transported to Parasitology laboratory in Jakarta.

2.4. DNA isolation and amplification ([@bb0140]) {#s0030}
------------------------------------------------

DNA was extracted from the cultures using QIAamp DNA Mini Kit following the procedure from the manufacturer (Qiagen, GmbH, cat no. 51306) and kept in −20 °C. PCR amplification of 18S rRNA was performed in 25 μl reaction with TopTaq Polymerase Master Mix Kit (Qiagen, cat no. 200403), 200 mM each dNTP, 10% Bovine Serum Albumin and 2 μl DNA template. The primers were as follows:Forward: RD5 5′-ATC-TGG-TTG-ATC-CTG-CCA-GT-3′Reverse: BhRDr 5′-GAG-CTT-TTT-AAC-TGC-AAC-AAC-G-3′

The PCR reactions were carried out on MJ Research PTC 200 thermocycler and adjusted for optimum reaction, consisted of: 1 cycle at 95 °C for 6 min then 30 cycles at 93 °C for 2 min, 65 °C for 2 min, 72 °C for 2 min. The last cycle was 10 min at 72 °C. The 600 bp PCR product was electrophoresed on 2% agarose gel and visualized with UV transilluminator.

2.5. DNA sequencing and subtype analysis {#s0035}
----------------------------------------

All the amplicons underwent bi-directional sequencing, the chromatograms were validated. Blasted sequences were aligned to *Blastocystis* database from the GenBank, using Mega 6 software ([en.bio-soft.net/tree/MEGA.htm](http://en.bio-soft.net/tree/MEGA.htm){#ir0005}). Phylogenetic tree was set up employing the Maximum Likelihood method and Kimura 2-parameter model ([@bb0070]). The tree with the highest log likelihood (−2575.97) is shown. Evolutionary analyses were conducted in MEGA X software ([@bb0075]).

2.6. Statistical analysis {#s0040}
-------------------------

Results were expressed as the mean and standard deviation (SD) for continuous variables and percentage for categorical data as univariate analysis. An independent sample *t*-test, Pearson chi-square test and/or Fisher\'s exact test were also used whenever appropriate and *P* value \<0.05 was considered statistically significant (95% confidence intervals). All *P values* were two sided. Data was analysed using SPSS v22.0 statistical package. The study was approved by the Ethics Committee, Faculty of Medicine, Universitas Indonesia (774/UN2.F1/ETIK/2017; 21st August 2017).

3. Results {#s0045}
==========

3.1. Risk factors to IBS {#s0050}
------------------------

[Table 1](#t0005){ref-type="table"} shows the profile of the study population. As many as 454 high school students were enrolled in this study, consisted of 37.2% males and 62.8% females; with average age of 15.8 ± 0.97 year. IBS was found in 137 students (30.2%). The risk factors related to IBS that showed significant associations can be classified into high risk (OR \> 3.0) consisted of family history of recurrent abdominal pain, psychosocial problems (abuse); moderate risk (2 \< OR ≤ 3), consisted of bullying, *Blastocystis* infection, female gender and history of constipation in respective order; and low risk (1.5 \< OR ≤ 2) consisted of grumpy father, particular diet (beverages, nuts, spicy soup) and history of diarrhoea.Table 1Assessment of the risk factors related to IBS (n = 454).Table 1CharacteristicIBS (+)IBS (−)Total*P valueOR95% CI*n (%)n (%)Age - 14--16 Y110 (80,3)225 (70,9)3350,051\*1,671025--2708 - 17--18 Y27 (19,7)92 (29,1)119Gender - Female102 (74,5)183 (57,7)285**0,001**\*2,131369--3326 - Male35 (25,2)134 (42,5)169Nutritional status - Malnourish37 (27,0)98 (30,9)1350,469\*0,830,529--1292 - Good100 (73,0)219 (69,1)319Gestational age - Preterm3 (2,2)5 (1,6)80,702\*\*1,400,329--5929 - A term134 (97,8)312 (98,4)446Birth weight - \<2500 g2 (1,5)3 (0,9)50,640\*\*1,560,256--9386 - ≥2500 g135 (98,5)314 (99,1)449No of sibling - ≤235 (25,5)79 (24,9)1140,981\*1,030,652 --1639 - \>2102 (74,5)238 (75,3)340Birth order - ≤3109 (79,6)277 (87,4)386**0,046**\*0,560,330--0,956 - \>328 (20,4)40 (12,6)68Parents\' marital status - Married116 (84,7)283 (89,3)3990,221\*0,660,370--1192 - Divorced21 (15,3)34 (10,7)55Mother\'s behavior - Grumpy45 (32,8)83 (26,2)1280,182\*1,380,892--2132 - Patient92 (67,2)234 (73,8)326Father\'s behavior - Grumpy35 (25,5)53 (16,7)88**0,040**\*1,711053--2774 - Patient102 (74,5)264 (83,3)366Psychosocial problems - Being attacked24 (37,5)40 (62,5)640,219\*\*1,470,847--2553 - Sexual abuse4 (100)0 (0)4**0,008**\*\*3,382934--3902 - Fighting29 (31,2)64 (68,8)930,912\*1,060,648--1738 - *Bullying*12 (52,2)11 (47,8)23**0,034**\*2,671148--6212 - Trauma18 (30,0)42 (70,0)601000\*0,990,548--1791 - Negative emotions33 (31,4)72 (68,6)1050,843\*1,080,674--1730 - *Abuse*2 (100)0 (0)20,091\*\*3,352907--3856Diet - Fish cake101 (31,0)225 (69,0)3260,629\*1,150,731--1801 - Sweet layer cakes6 (31,6)13 (68,4)191000\*1,070,398--2879 - Spicy soup (*Pindang*)84 (34,4)160 (65,6)244**0,043**\*1,561034--2339 - Steam spicy fish22 (29,7)52 (70,3)741000\*0,980,566--1680 - Milk100 (31,1)222 (68,9)3220,599\*1,160,740--1809 - Canned foods72 (31,7)155 (68,3)2270,540\*1,160,775--1729 - Processed meats60 (31,1)133 (68,9)1930,794\*1,080,719 -1616 - Nuts70 (38,9)110 (61,1)180**0,002**\*1,971309--2954 - Fried snacks125 (31,3)274 (68,7)3990,226\*1,600,813--3138 - Tea81 (31,0)180 (69,0)2610,719\*1,100,733--1653 - Coffee29 (26,6)80 (73,4)1090,417\*0,790,491--1288 - Beverages96 (35,7)173 (64,3)269**0,003**\*1,951271--2988Eating duration - ≤10 min10 (7,3)24 (7,6)3410000,960,447--2069 - \>10 min127 (92,7)293 (92,4)420Previous illness - Diarrhoea35 (41.2)50 (58.8)85**0.020**\*1.831.124--2.987 - Constipation24 (44.4)30 (55.6)54**0.023**\*2.031.139--3.626 - Food allergies22 (34.4)50 (58.8)720.520\*1.250.716--2.193Family history illness Recurrent abdominal pain6 (7.4)4 (3.57)100.073\*\*3.580.995--12.909[^1][^2]

3.2. Association between IBS and *Blastocystis* infection {#s0055}
---------------------------------------------------------

*Blastocystis* spp. was more prevalent among students with IBS than non-IBS (36.5% vs 28.6%) however there was no significant difference statistically (*P* = 0.325; PR = 1.4; 95% CI = 0.8--2.7). Students harbouring *Blastocystis* spp. infection had 1.6--1.8 times risk to suffer from IBS-Diarrhoea (IBS-D) or IBS-Unspecified (IBS-U) and unlikely to suffer from IBS-Constipation ([Table 2](#t0010){ref-type="table"}).Table 2Association between IBS, IBS types and *Blastocystis* infection.Table 2*Blastocystis* spp.IBSIBS categoryYes\
(n = 137)No\
(n = 70)IBS-DIBS-CIBS-MIBS-UYes50\
(36.5%)20\
(28.6%)216914No87\
(63.5%)50\
(71.4%)29202117PR (CI 95%)1.41.60.50.81.8(0.8--2.7)(0.8--3.1)(0.2--1.4)(0.3--1.8)(0.8--3.8)*P*[⁎](#tf0005){ref-type="table-fn"}0.3250.2180.3100.7880.214[^3][^4][^5][^6][^7][^8]

3.3. Association between *Blastocystis* strain with IBS type {#s0060}
------------------------------------------------------------

*Blastocystis* spp. was found in IBS and non-IBS subjects by direct stool microscopic examination i.e. in 50 out of 137 IBS subjects (36.5%) and 20 out of 70 non-IBS (28.6%). There were 43 out of 70 *Blastocystis* positive samples had successfully undergone PCR and sequencing ([Table 3](#t0015){ref-type="table"}). Three subtypes of *Blastocystis*, ST-1, ST-2 and ST-3 were identified ([Fig. 2](#f0010){ref-type="fig"}).Table 3Distribution of *Blastocystis* subtypes among IBS and its association with IBS type.Table 3*Blastocystis* strainIBSIBS typeYes\
(n-137)No\
(n = 70)IBS-DIBS-CIBS-MIBS-UST-1 (n = 20)15\
(10.9%)5\
(7.1%)9312ST-2 (n = 2)2\
(1.5%)0\
(0%)0020ST-3 (n = 21)14\
(10.2%)7\
(10.0%)3335[^9][^10][^11][^12][^13]Fig. 2Phylogenetic tree of *Blastocystis* spp. isolated from adolescences in Palembang (PLB).Fig. 2

There was higher proportion of ST-1 found in IBS group compared to the non-IBS (10.9% vs 7.1%), while ST-2 was found only in two students with IBS. The proportion of students harbouring *Blastocystis* ST-3 was similar between IBS and non-IBS (10.2% vs 10.0%); ST-3 did not show to affiliate to particular type of IBS ([Table 3](#t0015){ref-type="table"}).

Further analysis showed that students infected with *Blastocystis* ST-1 were 2.9 times more likely to develop IBS-D which was statistically significant (*Fisher*\'s *exact*, *P* = 0.029, *P* \< 0.05; 95% CI = 1.1--7.5). This finding suggests that ST-1 is likely to be the strain of *Blastocystis* associated with clinical manifestation IBS-diarrhoea type.

4. Discussion {#s0065}
=============

Irritable Bowel Syndrome is a common disorder among adolescences with higher prevalence in western than Asian countries and was believed as a functional bowel disorder ([@bb0035]; [@bb0030]; [@bb0130]) This study showed higher prevalence of IBS among high school students in Indonesia compared to other Asian countries ([@bb0035]; [@bb0030]; [@bb0040]). The prevalence of IBS varies greatly among epidemiological studies ([@bb0035]; [@bb0130]; [@bb0120]; [@bb0025]), potentially due to the criteria chosen to diagnose IBS, inclusion and exclusion criteria, gender distribution and sociodemographic factors. The Rome III Diagnostic Questionnaire for Paediatric Functional GI Disorders was used to diagnose IBS in this study ([@bb0065]) which is different from the adult questionnaire, in which criteria had to be fulfilled for the prior three months with symptoms onset at least six months prior to diagnosis.

The risk factors significantly associated to IBS have been identified and can be classified into high risk factors: family history of recurrent abdominal pain and abuse; moderate risk factors: bullying, *Blastocystis* infection, female gender, history of constipation in the last 6 months and low risk factors: beverages, nuts, previous illness diarrhoea. Our study showed a moderate risk for female students to develop IBS, which was also observed in other similar studies ([@bb0120]; [@bb0005]). The gender difference in developing IBS is less dramatic in developing countries compared to western population ([@bb0120]) which could be due to gender-related effects on intestinal motor and sensory pathway and function ([@bb0020]).

Negative emotion such as psychosocial problem and abuse have long been recognized to be associated with IBS in adolescences ([@bb0030]; [@bb0120]); while Park et al. specifically addressed that early adverse life events increased the odds of having IBS; correlated with IBS severity and abdominal pain ([@bb0100]). History of previous diarrhoea and constipation in the last six months also showed significant association with IBS with the risk factor about twice, suggesting a post infection-IBS resembling to IBS-D, as a common result of acute gastroenteritis ([@bb0050]). However, the risk factor of family history of recurrent abdominal pain has the highest odd to develop IBS, implying possibility of hereditary role in IBS.

There was a moderate risk for students harbouring *Blastocystis* infection to develop IBS. The overall prevalence of *Blastocystis* infection among the IBS group was higher than the non-IBS; more than one third of IBS students infected with *Blastocystis* spp. The IBS students harbouring *Blastocystis*, mostly suffered from IBS-diarrhoea (IBS-D) or IBS-U with estimated risk factor 1.6--1.8 times. Data prevalence of *Blastocystis* with IBS types was previously reported among adults and children \<5 years, which showed an association between IBS-D and *Blastocystis*; while no reports among adolescence. There had also been no previous clear reports on association between IBS type and *Blastocystis* strain ([@bb0175], [@bb0170]); therefore this is the first report on complete assessment of IBS and in-depth analysis on the role of *Blastocystis* to IBS among adolescence.

In view of its pathogenic and non-pathogenic *Blastocystis* strains, three *Blastocystis* subtypes, ST-1, ST-2 and ST-3 were identified in this study; no significant association with IBS was observed. However, there was significant association between *Blastocystis* ST-1 with IBS-Diarrhoea with the risk factor 2.9 times; suggesting that *Blastocystis* ST-1 is likely to associate to the clinical manifestation diarrhoea and possibility of being a pathogenic strain. *Blastocystis* ST-3 and ST-1 are the main subtypes found among populations in China, Japan, Bangladesh, Pakistan, Malaysia, Germany, Indonesia, Egypt ([@bb0135]; [@bb0095]; [@bb0185]; [@bb0055]; [@bb0160]).

In view of possible pathogenic ST-1 in our study is in accordance to other studies such as in Egypt by [@bb0055] who demonstrated *Blastocystis* ST-1, isolated from patient with IBS caused mortality in rats and severe pathological changes, while [@bb0045] reported severe inflammatory changes in recto sigmoidal biopsy of IBS patients harbouring *Blastocystis* ST-1. *Blastocystis* ST-1 was also commonly found among IBS-D in Pakistan ([@bb0180]). A meta-analysis by [@bb0125] involving 17 studies, showed the potential risk factors for IBS in patients infected by ST-1 and ST-3 subtypes with OR 4.40 and 1.94 respectively.

*Blastocystis* ST-3 was not associated with any IBS types; it is found in equal proportion among the four types of IBS. This finding is in agreement to [@bb0105], that showed phenotypic variation within *Blastocystis* ST-3.

The prevalence of *Blastocystis* was investigated only by microscopic methods in this study, which is not possible to determine the exact prevalence of *Blastocystis* infection in the study population. It is necessary to do culture for better accuracy of diagnostic purpose ([@bb0150]). As culture facilities at the sample collection area was not available, not all cultures grew well at room temperature and subsequently affected the proportion of positive PCR results and subtype analysis. This situation has significant limitations to the study. However, in primary healthcare setting, microscopic examination should be considered as first line screening when handling IBS-D cases.

5. Conclusion {#s0070}
=============

IBS in Indonesia was not merely functional bowel disorder, it has possible relationship with organic problem i.e. *Blastocystis* infection. Three subtypes of *Blastocystis* were observed (ST-1, ST-2 and ST-3) and ST-1 is considered to be a potential pathogenic species of *Blastocystis* spp., associated with IBS-diarrhoea type.
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[^1]: Chi square test (\*Continuity correction, \*\*Fisher\'s exact test).

[^2]: Bold values indicates significance at P\<0.05.

[^3]: Note:

[^4]: IBD-D = IBS with diarrhoea symptom.

[^5]: IBS-M = IBS mix with either diarrhoea or constipation episode.

[^6]: IBS-C = IBS with constipation symptom.

[^7]: IBS-U = IBS unclassified.

[^8]: Fisher\'s exact, *P* value = 0.05; PR = prevalence ratio; CI = confidence interval.

[^9]: Note:

[^10]: IBD-D = IBS with diarrhoea symptom.

[^11]: IBS-M = IBS mix with either diarrhoea or constipation episode.

[^12]: IBS-C = IBS with constipation symptom.

[^13]: IBS-U = IBS unclassified.
